In early studies of humans, baroreflex sensitivity was found to be higher during sleep; however, subsequent observations, in several species, including humans, have been at variance with the original reports. Sleep and arousal are behavioral states, and it is difficult to accurately and repeatedly measure baroreflex 
INTRODUCTION
In early studies of humans, baroreflex sensitivity was found to be higher during sleep (23, 24) ; however, subsequent observations, using various methods and in several species, including humans, have not consistently confirmed these observations. Sleep and arousal are behavioral states, and measuring baroreflex sensitivity in behaving animals is difficult; but, the EEG, and the component vascular, cardiac, and neural baroreflex responses of chronically maintained central nervous system intact neuromuscular blocked (NMB) rats can be accurately determined. (8, 9) .
Although NMB rats have distinct diurnal and sleep-wake cycles, our preliminary analyses showed that there was practically no time-of-day or EEG effects on baroreflex gain. This was not as anticipated 1 : In early observations in humans, with the Oxford pressor method that uses a vasoconstrictor to elevate blood pressure and challenge the baroreflex, Pickering, Sleight, and Smyth, (27) reported clear evidence of greater baroreflex gain during stage III & IV (slow wave; EEG δ ) sleep, and recently, with similar methods, Crisostomo et al. (5) found the same for African Americans and Caucasian men, but not Caucasian women. Similarly, using a sequence method that non-invasively analyzes heart period changes occurring during selected spontaneous blood pressure fluctuations, Parati et al. (22) found baroreflex sensitivity elevated during sleep.
Although the pressor and sequence methods have important differences, a common feature of both is that baroreflex gain is estimated entirely from the effects of blood pressure changes on heart period: The baroreflexes are a closed-loop system, and blood pressure cannot be, simultaneously, the independent and dependent variable. To estimate the vascular sympathoinhibitory component, Nakazato et al. (17) used a peroneal nerve recording: They found reduced pressor-elicited peroneal nerve sympathoinhibition during slow wave sleep (corresponding to lower vascular baroreflex sensitivity); whereas, heart period indicated slightly increased sensitivity. That heart period might not correlate well with the net baroreflex depressor action was first suggested in chronic dog studies using implanted carotid sinus nerve stimulators, which, during sleep, produced 12% to 22% greater, bradycardia, but no change in the net BP depressor effect (31).
Similarly, in baboons, using carotid occlusion to inhibit the baroreceptors, Combs et al. (3) found that during sleep, compared to the awake resting state, changes in heart period increased, in lower abdominal conductance remained the same, and in renal conductance decreased.
Most chronic animal studies of baroreflex gain and arousal have used behaving subjects, and have adapted human methods of baroreflex assessment.
Some have found an increased baroreflex sensitivity (based on heart period) during slow wave sleep; whereas, others have not. For example, in rats, using a validated sequence method, Oosting (21) found increased gain during "the sleeping period"; but, Zoccoli et al. (33) using a similar heart period regression measure, with more sophisticated criteria for sleep, reported that baroreflex gain was substantially independent of states of wakefulness, active sleep and quiet sleep.
Methodology may be responsible for the inconsistencies: In addition to the common limitation of measuring only heart period, the pressor and sequence 
METHODS
The general methods (except as noted) are identical to, and described in (8) . All actual surgery, or possibly irritating manipulation was done under controlled and carefully monitored, deep, isoflurane anesthesia. During surgery, the anesthetic level was >1.5 % isoflurane, which assured the following: (a) the EEG was synchronized and dominated by high voltage slow wave activity, (b) mean BP (femoral artery blood pressure) <100mmHg, HR < 420bpm, and (c) there were no evident EEG, BP, or HP (heart period;
interbeat interval, or R-R interval) responses to manipulation. During the 3-5 days following completion of surgery, after all wounds healed, anesthesia was gradually, withdrawn, and then, data collection began. During an NMB experiment, data collection is interrupted and anesthetic levels of isoflurane are re-instituted for any maintenance procedures that might produce discomfort; e.g., suction of the trachea, replacement of a bladder cannula, or removal of feces. Table 1 of (16)). The baroreflex test procedures are automated, and trials are presented on a pseudo-random, pre-determined schedule; thus, over hours and days, the exogenous barostimulation interacts freely with endogenous sleep cycles and other kinds of periodic and random variability in the physiological state.
Stimuli:
The stimulation parameters for the 30 s baroreflex test trials for EF and EH are described in (8) . In brief, the kinds of stimuli were: high frequency, low current ADN (A-fiber optimized); low frequency, high current ADN (C-fiber optimized), and carotid sinus balloon. Only the ADN results will be considered in detail (see fn. 3). The data from some ADN stimulation frequencies that were not included in the original analyses in (8) , were used here (The stimulus strength was above of the linear stimulus-response range, but elicited consistent baroreflex responses.) For each of rats EN, EO, FY and GF the trial sequences and procedures were the same as described in (8, 9) , but all test stimuli were set to a uniform single strength in the A-fiber range (40-75µA; 40 Hz; 100 µs). For EN, EO, FY and GF, all of the ADN test stimuli were of the same uniform level; thus, calculation of a gain ratio statistic was not necessary and the gain analysis, for these rats, was based on the magnitude of the raw BP change to that rat's particular ADN stimulus. All stimuli were 40ips, 100µS pulses; the current (40-75 µA) for each rat was set at approximately the median of the A-fiber range, with the particular range, for each rat, determined by the procedure described in (8) .
EEG electrodes: The electrode placements are based on Friedman (10) and Mistlberger (16) Measurement and recording of cardiovascular variables and description of materials and their sources is in (8) . The data resolution was at least one systolic and diastolic sample per heart beat, continuous; increased to 6000 samples per second (6 KS/s) during stimulations. activity (e.g. at hours 2, 10 and 18), heart rate, BP, systolic femoral flow, vagus nerve activity, and peroneal nerve activity all dip to lower average levels. In a parallel analysis to that used with EF & EH (but based on raw HP and BP changes rather than gain ratios), the data from EN, EO, FY and GF was z-scored and combined into a single set: The overall HP-EEG δ regression was r = .491 (df = 819; p<.0001), and the BP-EEG δ regression was r = .027 (df =819; NS).
RESULTS

Properties of the preparation:
Thus, the analysis of each of the 6 NMB rats shows a strong, statistically reliable, enhancement, at higher EEG δ levels (i.e., lower arousal) of HP baroreflex sensitivity, but no enhancement of BP baroreflex sensitivity.
<Table 1 Goes Here>
DISCUSSION
The heart period result ( 
<Figure 7 Goes Here>
Why does arousal affect baroreflex heart period responses differently than blood pressure responses? The partial correlations analysis, for rats EF and EH,((28); Appendix) shown in Fig. 7 addresses this question by using the EEG δ -baseline (Fig.4) , and the baseline-gain relationships (Fig.5) to dissect the EEG δ -gain relationships (Fig. 6 ) for HP and BP: Fig. 4 shows that both baselines depend on EEG δ : the heart period becomes longer and the blood pressure lower during slow wave sleep. Fig. 5 shows that the BP gain ratio is strongly coupled to the BP baseline (cf. Fig. 2 in (19) ); this means that changes in EEG δ will be transmitted through the blood pressure baseline relationship to the gain-ratio (Fig. 7 bottom) . Because, the BP baseline decreases with EEG δ , the predicted effect of sleep (increased EEG δ ) through this compound path is to reduce the gain-ratio. However, Fig. 6 shows that the BP gain-ratio, in fact, does not change with EEG δ ; consequently, by implication, another mechanism, one that increases gain with sleep, is also operating.
The HP result buttresses the BP analysis: Similar to BP, the HP baseline depends on arousal (Fig. 4) ; however in contrast to BP, the HP gain-ratio does not increase with the HP baseline (Fig. 5) ; thus, arousal does not increase HP gain through this path (Fig. 7, top) , and the direct relationship between arousal and HP gain (Fig. 6 ) is unopposed. Table 1 ).
In sum, using direct open-loop baroreflex measurements, we found that, during periods of higher EEG δ , an ADN stimulus produced a larger bradycardia, but not a larger BP depressor response. The partial correlations analysis deciphers this result and suggests a possible heuristic to the physiological mechanisms.
Fictive arousal can be produced in anesthetized animals by hypothalamic and periaqueductal grey electrical stimulation: Hilton (4, 11, 12) showed that hypothalamic defense area (HDA) stimuli effectively block, either CVLM inhibitory interneurons (GABA) project to sympathetic premotor neurons in the rostral ventrolateral medulla (RVLM). These RVLM neurons have tonic activity, which may, or may not, depend on obligatory exogenous sources of excitation (1, cf.30) , for example, from the hypothalamus. In NMB rats (Fig. 3) , sympathetic (peroneal) nerve activity is lower at higher EEG δ ; thus, it is probable that RVLM presympathetic activity (the substrate of baroreflex inhibition) is also lower. In early studies with anesthetized rats, fictive arousal via hypothalamic stimulation excited kynurenate sensitive presympathetic neurons in the RVLM and increased lumbar sympathetic nerve discharge, but did not affect sympathetic nerve baroreflex gain(29); however, recent studies in unanesthetized rabbits have shown that kynurenate in the RVLM, decreases the renal sympathetic baroreflex gain (14) . Given these findings, in the RVLM, lower arousal and reduced sympathetic activity, via higher EEG δ , would be expected to diminish sympatho-vascular (BP) baroreflex sensitivity. Thus, RVLM effects of arousal on baroreflex gain are likely to be opposite to those in the NTS.
In The experimental animal literature does not support either the assumption or the conclusion: Although for methodological reasons, the focus of animal neurophysiological studies has been the heightened arousal of "fight or flight", rather than the lowered arousal of sleep, an early study in chronic dogs, using sinus nerve stimulation (31), found that HP, but not BP gain was increased in sleep. Our observations of CNS-intact NMB rats, confirm and extend these earlier findings, and underline that the heart period baroreflex is not always a reliable estimate of the blood pressure baroreflex 4 . notation is consistent across all 6 rats, e.g., for BRX×EEG, indicates that the baroreflex response was larger, for higher EEG δ values (i.e., for lower arousal).
APPENDIX
For rat EO, 24 measurements with baseline BP>170mmHg were excluded from the calculations in this table, because these were due to a transducer artifact, and probably erroneous. N.B. for the six blood pressure BRX×EEG correlations, five are effectively zero, the sixth (EH) is statistically reliable, but in the direction of decreased baroreflex gain with sleep, which is opposite to the usual expectation. 33. Zoccoli G, Andreoli E, Bojlc T, Cianci T, Franzini C, Predieri S, and Lenzi P. Central and baroreflex control of heart rate during the wake-sleep cycle in rat. Footnotes 1 However, NMB rats have no respiratory or skeletal muscle activity, and it seemed plausible that these functions might be requisite to the effects of arousal on baroreflex gain. 2 In classifying sleep stages the distinction between wakefulness and REM sleep involves measures of skeletal muscle activity in the form of atonia and rapid eyemovements, however, the identification of "quiet" sleep can be made entirely on the basis of the EEG δ . NMB rats have no skeletal muscle activity; however, because the activity in skeletal nerve is not directly affected by the α-ctx pharmacological block, it is possible to monitor efferent nerve activity attendant upon skeletal outflow. We did not do this in the same subjects that were used for measurements of baroreflex gain, but data from other long-term NMB rats shows the expected relationship between EEG δ and skeletal nerve activity (see Fig. 1, 6 & 11 of (7) ). 3 Having included the results of sinus stimulation, other EEG measures, or the three additional rats (DU, EC and EG) described in (8) ; (9) would not have substantially changed any of the results: For all five rats, for both the ADN electrode and sinus balloon stimulation, neither heart period (HP) or blood pressure (BP) measures of the baroreflex gain ratio were dependent on the EEG θ or EEG β amplitude. Although the HP (r = 0.18; p<001) and BP (r = 0.17; p<.005) gain ratios increased at higher EEG α ; compared to EEG δ , these effects were weak, and unlike EEG δ , EEG α lacks a generally accepted relationship to sleep and arousal. For rats DU, EF and EH, the sinus elicited HP was completely unaffected by EEG δ , but, in fact, the sinus HP effects are very small (see Table 1 & Fig 6 (9) ), and EEG dependence, if present, would have been difficult to detect. 4 Measurement of the VLF noise spectrum is a non-invasive method of directly assessing changes in vascular (BP) baroreflex gain. (see page R1931 of (9)). 5 For EF the correlation between the BP gain ratio and EEG δ increased from .057 to .293 (df=303; p<.0005), and for EH the correlation increased from -.262 to .127 (df=122; p<.0005); whereas, the change in the HP gain ratio correlation was not reliable for either rat. 24h  23  22  21  20  19  18  17  16  15  14  13  12  11  10  9  8  7  6  5  4  3 Heart Period Gain Ratio
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